Inventor · disambiguated record
Stefano Crosignani
Also filed as: CROSIGNANI STEFANO
24 granted patents·13 pending applications·75 citations·filing 2005–2022
93Inventor score
Top patents by PatentIndex Score
37 records- 0194US9126984B24-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for useITEOS THERAPEUTICS·Filed 2013·Granted Sep 8, 2015·34 cites·13 claims
- 0281US9216991B2Pyrimidine pyrazolyl derivativesARES TRADING SA·Filed 2013·Granted Dec 22, 2015·6 cites·15 claims
- 0380US9567320B2Pyridazinone-amides derivativesMERCK PATENT GMBH·Filed 2014·Granted Feb 14, 2017·4 cites·7 claims
- 0480US8202865B2Oxadiazole derivativesQUATTROPANI ANNA·Filed 2008·Granted Jun 19, 2012·7 cites·37 claims
- 0578US10398679B2Treatment method utilizing pyrrolidine-2, 5-dione derivatives as IDO1 inhibitorsITEOS THERAPEUTICS·Filed 2018·Granted Sep 3, 2019·2 cites·20 claims
- 0677US9949951B2Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitorsITEOS THERAPEUTICS·Filed 2016·Granted Apr 24, 2018·2 cites·24 claims
- 0777US9603836B2Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitorsITEOS THERAPEUTICS·Filed 2015·Granted Mar 28, 2017·2 cites·55 claims
- 0875US8236963B2Tricyclic spiro derivatives as CRTH2 modulatorsSCHWARZ MATTHIAS·Filed 2006·Granted Aug 7, 2012·5 cites·22 claims
- 0973US11376255B2Thiocarbamate derivatives as A2A inhibitors, pharmaceutical composition thereof and combinations with anticancer agentsiTeos Belgium SA·Filed 2020·Granted Jul 5, 2022·1 cites·6 claims
- 1073US9073892B2Indazolyl triazol derivativesJORAND-LEBRUN CATHERINE·Filed 2011·Granted Jul 7, 2015·7 cites·28 claims
- 1169US8802704B2Oxadiazole derivativesQUATTROPANI ANNA·Filed 2010·Granted Aug 12, 2014·1 cites·7 claims
- 1268US9873690B23-indol substituted derivatives, pharmaceutical compositions and methods for usePFIZER·Filed 2016·Granted Jan 23, 2018·1 cites·9 claims
- 1368US9688702B2Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitorsARES TRADING SA·Filed 2012·Granted Jun 27, 2017·2 cites·16 claims
- 1468US8247437B2N-hydroxyamide derivatives and use thereofSWINNEN DOMINIQUE·Filed 2011·Granted Aug 21, 2012·1 cites·20 claims
- 1568US2023098694A1Non brain penetrant a2a inhibitors and methods for use in the treatment of cancersITEOS BELGIUM S A·Filed 2022·Application pending·0 cites
- 1663US2023159564A12-Oxo-Thiazole Derivatives as A2A Inhibitors and Compounds for Use in the Treatment of CancersiTeos Belgium SA·Filed 2022·Application pending·0 cites
- 1762US11427594B2Non brain penetrant A2A inhibitors and methods for use in the treatment of cancersiTeos Belgium SA·Filed 2019·Granted Aug 30, 2022·0 cites·2 claims
- 1855US2023407352A1Method for the Production of Thiocarbamate Derivatives A2AR InhibitorsiTeos Belgium SA·Filed 2021·Application pending·0 cites
- 1953US10995101B22-oxo-thiazole derivatives as A2A inhibitors and compounds for use in the treatment of cancersITEOS THERAPEUTICS SA·Filed 2019·Granted May 4, 2021·0 cites·22 claims
- 2053US2021198281A12-oxo-thiazole derivatives as a2a inhibitors and compounds for use in the treatment of cancersITEOS THERAPEUTICS SA·Filed 2020·Application pending·0 cites
- 2153US2016263087A1Novel 4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for useITEOS THERAPEUTICS·Filed 2014·Application pending·0 cites
- 2252US8008302B2N-hydroxyamide derivatives and use thereofMERCK SERONO SA·Filed 2005·Granted Aug 30, 2011·0 cites·24 claims
- 2351US8399448B26-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosisBOMBRUN AGNES·Filed 2008·Granted Mar 19, 2013·0 cites·12 claims
- 2450US2011028509A1SulfonamidesMERCK SERONO SA·Filed 2009·Application pending·0 cites
- 2549US9150519B26-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosisMERCK SERONO SA·Filed 2012·Granted Oct 6, 2015·0 cites·4 claims
- 2649US2023121530A1Thiocarbamate derivatives as a2a inhibitors, pharmaceutical composition thereof and combinations with anticancer agentsiTeos Belgium SA·Filed 2022·Application pending·0 cites
- 2747US10945994B2Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-bodyPFIZER·Filed 2016·Granted Mar 16, 2021·0 cites·26 claims
- 2847US2015328228A1Novel 4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for useITEOS THERAPEUTICS·Filed 2015·Application pending·0 cites
- 2946US2017071936A1Pyridazinone-amides derivativesMERCK PATENT GMBH·Filed 2016·Application pending·0 cites
- 3044US8815919B2Oxadiazole derivativesQUATTROPANI ANNA·Filed 2010·Granted Aug 26, 2014·0 cites·5 claims
- 3142US2021338672A1Use of an inhibitor of an ent family transporter in the treatment of cancer and combination thereof with an adenosine receptor antagonistiTeos Belgium SA·Filed 2019·Application pending·0 cites
- 3238US10544095B23-indol substituted derivatives, pharmaceutical compositions and methods for usePFIZER·Filed 2016·Granted Jan 28, 2020·0 cites·7 claims
- 3332US9758505B23-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for useITEOS THERAPEUTICS·Filed 2015·Granted Sep 12, 2017·0 cites·15 claims
- 3432US2015266857A1Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for useITEOS THERAPEUTICS·Filed 2015·Application pending·0 cites
- 3527US2012115869A1Tetrazole derivativesCROSIGNANI STEFANO·Filed 2010·Application pending·0 cites
- 3625US8273769B2Phenoxy acetic acid derivativesCROSIGNANI STEFANO·Filed 2010·Granted Sep 25, 2012·0 cites·12 claims
- 3725US2012115895A1Tricyclic indole-derived spiro derivatives as crth2 modulatorsCROSIGNANI STEFANO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefano Crosignani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →